-
1 month ago | 
pharmaceutical-journal.com | Antimicrobial resistance |Corrinne Burns
A “UK-first” rapid genetic sequencing method could help to improve antimicrobial stewardship in hospitals by diagnosing bacterial infections faster and more accurately, the Medicines and Healthcare products Regulatory Agency (MHRA) has said.
-
1 month ago | 
pharmaceutical-journal.com | Antimicrobial resistance |Sasa Jankovic
The UK is “a long way” from achieving its targets for reducing antimicrobial resistant infections, according to a report by the National Audit Office (NAO). The report, published on 26 February 2025, assessed the risk posed by antimicrobial resistance (AMR) and the UK government’s response. It noted that, despite government targets, there had been “no sustained reduction” in the amount of AMR-related human infections that the government tracks.
-
Jan 20, 2025 | 
pharmaceutical-journal.com | Antimicrobial resistance |Corrinne Burns
Olivier Picard, board member of the National Pharmacy Association (NPA), has said that community pharmacy has the ability to “unleash the potential” of vaccines to combat antimicrobial resistance (AMR).
-
Jan 14, 2025 | 
bmcglobalpublichealth.biomedcentral.com | Antimicrobial resistance
ReferencesGovernment launches NHS Test and Trace service. https://www.gov.uk/government/news/government-launches-nhs-test-and-trace-service. NHS to ramp up coronavirus testing labs. https://www.england.nhs.uk/2020/03/nhs-to-ramp-up-coronavirus-testing-labs/. Testing for coronavirus (COVID-19) will increase to 25,000 a day. https://www.gov.uk/government/news/testing-for-coronavirus-covid-19-will-increase-to-25-000-a-day.
-
Dec 11, 2024 | 02706-5/abstract?hss_channel=tw-27013292&dgcid=twitter_organic_comment25_lancet&sz=64)
thelancet.com | Swiss Tropical |Antimicrobial resistance
aDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK bNational Institute for Medical Research, Dar es Salaam, Tanzania cDepartment of Biochemistry, Kampala International University in Tanzania, Dar es Salaam, Tanzania dMalaria Elimination Initiative, Institute of Global Health Sciences, University of California San Francisco, San Francisco, CA, USA eDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA fMahidol Oxford...
-
Dec 4, 2024 | 
microbiologyresearch.org | William Matlock |Liam Shaw |Nicole Stoesser |Antimicrobial resistance
Article metrics loading... /content/journal/mgen/10.1099/mgen.0.001312Download as PowerPoint
/deliver/fulltext/mgen/10/12/mgen001312.html?itemId=/content/journal/mgen/10.1099/mgen.0.001312&mimeType=html&fmt=ahah
References Baquero F, Martínez JL, F Lanza V, Rodríguez-Beltrán J, Galán JC et al. Evolutionary pathways and trajectories in antibiotic resistance. Clin Microbiol Rev 2021; 34:e0005019 [View Article] [PubMed][Google Scholar] Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A et al.
-
Sep 26, 2024 | 
pharmaceutical-journal.com | Antimicrobial resistance |Sophie Willis
Antimicrobial resistance (AMR) is a rapidly growing global challenge. In 2019, bacterial AMR infections were estimated to have directly caused 1.27 million global deaths and, by 2050, a study published in The Lancet in September 2024 suggested that it could cause 39 million more. Listed by the World Health Organization (WHO) as in November 2023, AMR is fuelled by high levels of antibiotic prescribing.
-
Sep 16, 2024 | 
pharmaceutical-journal.com | Antimicrobial resistance |Sophie Willis
Antibiotic-resistant infections could cause more than 39 million deaths across the world between now and 2050, according to a study published in The Lancet. The findings, published on 16 September 2024, suggest that deaths from antimicrobial resistance (AMR) will rise by almost 70% in 2050 compared with 2022, with people aged over 70 years the worst affected.
-
Aug 29, 2024 | 00190-7/fulltext?rss=yes&sz=64)
journalofinfection.com | Antimicrobial resistance
Keywords Bacterial Infections Epidemiology COVID-19 Gram-Negative Bacterial Infections Mortality Introduction In the United Kingdom (UK), disruption to healthcare services during the COVID-19 pandemic and health protection measures implemented to control the spread of COVID-19 significantly changed the epidemiology of Gram-Negative Bloodstream Infections (GNBSIs).1,2 Surveillance data from England reported that the rates of Hospital-Onset (HO) GNBSIs during the pandemic were higher than...
-
Aug 22, 2024 | 
academic.oup.com | Antimicrobial resistance
Overall, infection was the underlying cause of death for 11.7% (89/758) of participants and was implicated in the pathway that led to death in 41.1% (357/758) of cases. The most common infection syndromes leading to death as documented on the medical certificate of confirmation of death (MCCD) were respiratory tract infections, sepsis and COVID-19. In total, 4.2% (32/758) of all deaths were AMR-attributable.
